Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

SR-49059: a selective vascular V1 receptor antagonist

June 25, 1997

Pharmacokinetics and antihypertensive efficacy of the new AII antagonist CS-866

June 25, 1997

LU-135252 evaluated in models of acute renal failure and hypertension

June 25, 1997

ET antagonists prepared at Roussel Uclaf

June 25, 1997

Preclinical studies on UR-7280, a potential antihypertensive agent

June 23, 1997

Merck & Co. reports NOS inhibitors

June 20, 1997

Coreg now available in the U.S. for heart failure

June 18, 1997

Vasopressin and/or oxytocin receptor ligands described by Sanofi

June 18, 1997

Proischemic effect of enalapril in MI

June 17, 1997

Yamanouchi discloses new Na+/H+ exchange inhibitors

June 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...